HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.

Abstract
Microvascular inflammation occurs during sepsis and the endogenous opioid-like peptide nociceptin/orphanin FQ (N/OFQ) is known to regulate inflammation. This study aimed to determine the inflammatory role of N/OFQ and its receptor NOP (ORL1) within the microcirculation, along with anti-inflammatory effects of the NOP antagonist UFP-101 (University of Ferrara Peptide-101) in an animal model of sepsis (endotoxemia). Male Wistar rats (220 to 300 g) were administered lipopolysaccharide (LPS) for 24 h (-24 h, 1 mg kg(-1); -2 h, 1 mg kg(-1) i.v., tail vein). They were then either anesthetised for observation of the mesenteric microcirculation using fluorescent in vivo microscopy, or isolated arterioles (~200 µm) were studied in vitro with pressure myography. 200 nM kg(-1) fluorescently labelled N/OFQ (FITC-N/OFQ, i.a., mesenteric artery) bound to specific sites on the microvascular endothelium in vivo, indicating sparse distribution of NOP receptors. In vitro, arterioles (~200 µm) dilated to intraluminal N/OFQ (10(-5)M) (32.6 + 8.4%) and this response was exaggerated with LPS (62.0 +7.9%, p=0.031). In vivo, LPS induced macromolecular leak of FITC-BSA (0.02 g kg(-1) i.v.) (LPS: 95.3 (86.7 to 97.9)%, p=0.043) from post-capillary venules (<40 µm) and increased leukocyte rolling as endotoxemia progressed (p=0.027), both being reduced by 150 nmol kg(-1) UFP-101 (i.v., jugular vein). Firstly, the rat mesenteric microcirculation expresses NOP receptors and secondly, NOP function (ability to induce dilation) is enhanced with LPS. UFP-101 also reduced microvascular inflammation to endotoxemia in vivo. Hence inhibition of the microvascular N/OFQ-NOP pathway may have therapeutic potential during sepsis and warrants further investigation.
AuthorsZoë L S Brookes, Emily N Stedman, Nicola J Brown, Christopher P Hebbes, Remo Guerrini, Girolamo Calo, Charles S Reilly, David G Lambert
JournalPloS one (PLoS One) Vol. 8 Issue 9 Pg. e74943 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24086402 (Publication Type: Journal Article)
Chemical References
  • (Nphe(1),Arg(14),Lys(15))N-OFQ NH(2)
  • Narcotic Antagonists
  • Opioid Peptides
  • Receptors, Opioid
  • Recombinant Proteins
  • nociceptin
  • Fluorescein-5-isothiocyanate
  • Nociceptin Receptor
Topics
  • Animals
  • CHO Cells
  • Cardiovascular System (drug effects, pathology, physiopathology)
  • Cricetinae
  • Cricetulus
  • Fluorescein-5-isothiocyanate (metabolism)
  • Inflammation (metabolism, pathology)
  • Leukocyte Rolling (drug effects)
  • Male
  • Microcirculation (drug effects)
  • Microvessels (drug effects, pathology)
  • Narcotic Antagonists
  • Opioid Peptides (metabolism, pharmacology)
  • Rats
  • Rats, Wistar
  • Receptors, Opioid (metabolism)
  • Recombinant Proteins (metabolism)
  • Nociceptin Receptor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: